Nicolas Sergeant

This inventor holds 12 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: National Institute of Health and Medical Research, Alzprotect, Université De Lille 2 Droit Et Santé. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicolas Sergeant. Retrieved from https://idiyas.com/inventor/nicolas-sergeant

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 3)

% Patents Active = 83.3

CIPO Patents = 3

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 14(Granted Patents)

Location History:

Ronchin, FR (2010 - 2020)
Lille, FR (2017 - 2020)

Company Filing History:

11 out of 1,853

National Institute of Health and Medical Research

Université De Lille 2 Droit Et Santé

patents

4. 2 out of 24

Association Institut De Myologie

patents

5. 2 out of 5,383

Centre National De La Recherche Scientifique

patents

6. 2 out of 158

Université Pierre Et Marie Curie (Paris 6)

patents

7. 1 out of 10

Centre Hospitalier Regional Et Universitaire De Lille (Chru)

patents

8. 1 out of 26

Centre Hospitalier Régional Universitaire De Lille

Université De Droit Et De La Santé De Lille 2

patents

12. 1 out of 1

Universite De Lille 2 Droit Et Saute

patent

13. 1 out of 1

Universite Du Droit Et De La Santa-Lille Ii

patent

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12503495 - TREATMENT OF MYOTONIC DYSTROPHY (2025-12-23),

2. 10807958 - 1,4-bis(3-aminopropyl)piperazine derivative and its use (2020-10-20),

3. 10799556 - Treatment of myotonic dystrophy (2020-10-13),

4. 10772884 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same (2020-09-15),

5. 10537569 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same (2020-01-21),

6. 10017476 - 1,4-bis(3-aminopropyl)piperazine derivative and its use (2018-07-10),

7. 9759728 - Methods for determining human sperm quality (2017-09-12),

8. 9714245 - Carboline compounds usable in the treatment of neurodegenerative diseases (2017-07-25),

9. 9562018 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same (2017-02-07),

10. 9044478 - Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases (2015-06-02),

11. 8343493 - Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs (2013-01-01),

12. 7723117 - Means for detecting pathological transformation of the APP protein and their uses (2010-05-25),

Title: Innovations and Contributions of Inventor Nicolas Sergeant

Introduction

Nicolas Sergeant is a prominent inventor based in Ronchin, France. He has made significant contributions to the field of medical research, particularly in the treatment of neurological disorders. With a total of 11 patents to his name, Sergeant's work has garnered attention for its potential impact on healthcare.

Latest Patents

Among his latest patents is the invention of a 1,4-bis(3-aminopropyl)piperazine derivative and its use. This invention relates to a compound that has the potential to treat and/or prevent Tauopathy, a condition associated with neurodegenerative diseases. Another notable patent focuses on the treatment of myotonic dystrophy, detailing compositions and methods aimed at alleviating this genetic disorder.

Career Highlights

Throughout his career, Nicolas Sergeant has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and Alzprotect. His work in these institutions has allowed him to advance his research and contribute to significant medical advancements.

Collaborations

Sergeant has collaborated with notable colleagues, including Luc Buee and Patricia Melnyk. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his research.

Conclusion

Nicolas Sergeant's innovative work and dedication to medical research have positioned him as a key figure in the field. His patents reflect a commitment to improving treatment options for patients with complex neurological conditions.

Profile summary based on public USPTO records.